tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
Company profile
Ticker
THQ
Exchange
CEO
Daniel R. Omstead
Employees
Incorporated
Location
Fiscal year end
Former names
Tekla Healthcare Growth & Income Fund
SEC CIK
IRS number
465317248
THQ stock data
Latest filings (excl ownership)
N-CEN
Annual report (registered investment company)
12 Dec 23
N-CSR
Certified annual shareholder report (management investment company)
11 Dec 23
DEFA14A
Additional proxy soliciting materials
13 Oct 23
DEFA14A
Additional proxy soliciting materials
10 Oct 23
DEFA14A
Additional proxy soliciting materials
5 Oct 23
DEFA14A
Additional proxy soliciting materials
3 Oct 23
DEFA14A
Additional proxy soliciting materials
2 Oct 23
POS EX
Additional exhibits for listing
27 Sep 23
DEFA14A
Additional proxy soliciting materials
15 Sep 23
DEFA14A
Additional proxy soliciting materials
15 Sep 23
Latest ownership filings
4
Kathleen Goetz
12 Apr 24
3
Loretta Tse
22 Mar 24
NPORT-P
abrdn Healthcare Opportunities Fund (Dec 2023 report)
29 Feb 24
4
Todd Reit
4 Jan 24
4
Bill Maher
2 Jan 24
3
Joshua Duitz
22 Dec 23
3
Ben Ritchie
22 Dec 23
3
Jason Akus
22 Dec 23
NPORT-P
Tekla Healthcare Opportunities Fund (Sep 2023 report)
15 Nov 23
3
Lucia Sitar
6 Nov 23
Funds
Series | Ticker | %Monthly Return ? | $Assets | #Holdings | As of | ||
---|---|---|---|---|---|---|---|
Tekla Healthcare Opportunities Fund | – | 1.95 | -2.88 | -8.40 | 1.06 bn | 144 | Sep 2023 |
Institutional ownership, Q3 2023
22.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 89 |
Opened positions | 18 |
Closed positions | 4 |
Increased positions | 31 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 151.43 bn |
Total shares | 9.13 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MS Morgan Stanley | 1.60 mm | $27.11 bn |
Raymond James Financial Services Advisors | 986.43 k | $16.75 bn |
RY Royal Bank Of Canada | 834.93 k | $14.18 bn |
Raymond James & Associates | 767.17 k | $13.03 bn |
Cornerstone Advisors | 403.97 k | $6.86 bn |
1607 Capital Partners | 398.27 k | $6.76 bn |
Heron Bay Capital Management | 376.21 k | $6.39 bn |
AMP Ameriprise Financial | 312.98 k | $5.32 bn |
UBS UBS Group AG - Registered Shares | 312.70 k | $5.31 bn |
Steward Partners Investment Advisory | 235.47 k | $4.00 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Apr 24 | Kathleen Goetz | Common Stock | Buy | Acquire P | No | No | 19.5381 | 600 | 11.72 k | 1,148.188 |
2 Jan 24 | Todd Reit | Common Stock | Buy | Acquire P | No | No | 18.436 | 1,000 | 18.44 k | 1,000 |
28 Dec 23 | Bill Maher | Common Stock | Buy | Acquire P | No | No | 18.25 | 1,000 | 18.25 k | 1,000 |